|Articles|August 1, 2012
- Pharmaceutical Executive-08-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - August 2012
Piramal Pivots for Growth
Advertisement
Articles in this issue
about 14 years ago
Country Report: Mexicoabout 14 years ago
Sunny Outlook for Biopharm 2020?about 14 years ago
The Phrase that Playsabout 14 years ago
Planning that Thousand Year FutureAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5